EP3321270
SODIUM (2R, 5S, 13AR)-7, 9-DIOXO-10- ((2,4,6-TRIFLUOROBENZYL)CARBAMOYL)-2, 3, 4, 5, 7, 9, 13,13A-OCTAHYDRO-2,5-METHANOPYRIDO [1',2':4.5] PYRAZINO [2, 1-B] OXAZEPIN-8-OLATE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
19.6.2015EP published:
4.12.2024EP application number:
17204116.2
EPO information:
European Patent Register
Max expiry date:
18.6.2035
Title in English:
SODIUM (2R, 5S, 13AR)-7, 9-DIOXO-10- ((2,4,6-TRIFLUOROBENZYL)CARBAMOYL)-2, 3, 4, 5, 7, 9, 13,13A-OCTAHYDRO-2,5-METHANOPYRIDO [1',2':4.5] PYRAZINO [2, 1-B] OXAZEPIN-8-OLATELanguage of the patent:
English
Timeline
Today
19.6.2015EP application
4.12.2024EP Publication
Owner
Name:
Gilead Sciences, Inc.Address:
333 Lakeside Drive, Foster City, CA 94404, US
Inventor
Name:
CARRA, Ernest A.Address:
Foster City, CA 94404, US
Name:
CHEN, IreneAddress:
Foster City, CA 94404, US
Name:
ZIA, VahidAddress:
Foster City, CA 94404, US
Priority
Number:
201462015245 PDate:
20.6.2014Country:
US
Classification
Categories:
C07D 498/14, A61K 31/683, A61P 31/18, A61K 45/06, A61K 9/20, A61K 31/513, A61K 31/553, A61K 31/675, C07D 498/18, A61P 31/00, A61P 43/00